Xilio Therapeutics Inc (XLO): Next-Year EPS Estimate 115.06%
As of 2026-05-12, Xilio Therapeutics Inc (XLO) has a next-year EPS growth estimate of 115.06%.
Analyst estimates for XLO have remained steady in the most recent observable window, with next-year EPS growth projected at 115.06%. Current-year growth stands at 42.96%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 115.06%
- EPS growth this year
- 42.96%
- EPS next quarter (est)
- -$0.58
- Last price
- $7.73
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-12 | 115.06% | 42.96% | -$0.58 | $7.73 |
| 2026-05-11 | 115.06% | 42.96% | -$0.66 | $7.73 |
| 2026-05-10 | 115.06% | 42.96% | -$0.66 | $7.74 |
| 2026-05-07 | 115.06% | 42.96% | -$0.66 | $7.81 |
| 2026-05-06 | 115.06% | 42.96% | -$0.66 | $7.90 |
| 2026-05-05 | 115.06% | 42.96% | -$0.66 | $7.71 |
| 2026-05-04 | 115.06% | 42.96% | -$0.66 | $8.33 |
| 2026-05-03 | 115.06% | 42.96% | -$0.66 | $8.32 |
| 2026-04-30 | 115.06% | 42.96% | -$0.66 | $7.92 |
| 2026-04-29 | 115.06% | 42.96% | -$0.66 | $7.79 |
| 2026-04-28 | 115.06% | 42.96% | -$0.66 | $7.92 |
| 2026-04-27 | 115.06% | 42.96% | -$0.66 | $8.18 |
| 2026-04-26 | 115.06% | 42.96% | -$0.66 | $8.31 |
| 2026-04-24 | 115.06% | 42.96% | -$0.66 | $8.31 |
| 2026-04-23 | 115.06% | 42.96% | -$0.66 | $8.47 |
| 2026-04-22 | 115.06% | 42.96% | -$0.66 | $8.60 |
| 2026-04-21 | 115.06% | 42.96% | -$0.66 | $8.52 |
| 2026-04-20 | 115.06% | 42.96% | -$0.66 | $8.45 |
| 2026-04-19 | 115.06% | 42.96% | -$0.66 | $8.57 |
| 2026-04-16 | 115.06% | 42.96% | -$0.66 | $8.35 |
| 2026-04-15 | 115.06% | 42.96% | -$0.66 | $8.40 |
| 2026-04-14 | 115.06% | 42.96% | -$0.66 | $8.59 |
| 2026-04-13 | 115.06% | 42.96% | -$0.66 | $8.46 |
| 2026-04-12 | 115.06% | 42.96% | -$0.66 | $8.51 |
| 2026-04-10 | 115.06% | 42.96% | -$0.66 | $8.69 |
| 2026-04-09 | 115.06% | 42.96% | -$0.66 | $8.56 |
| 2026-04-08 | 115.06% | N/A | -$0.66 | $8.69 |
| 2026-04-07 | 115.06% | N/A | -$0.66 | $8.50 |
| 2026-04-06 | 115.06% | N/A | -$0.66 | $8.50 |
| 2026-04-05 | 115.06% | N/A | -$0.66 | $8.51 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Xilio Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-05-12, Xilio Therapeutics Inc (XLO) has a next-year EPS growth estimate of 115.06%, based on analyst consensus.
What sector and industry does Xilio Therapeutics Inc belong to?▾
Xilio Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. XLO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Xilio Therapeutics Inc (XLO) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports